Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
[49]Yu G, Chen Q, et al
Once approved, here is what the pricing landscape looks like based on comparable drugs: Semaglutide (Wegovy) without insurance runs $1,300 to $1,600 per month in the US Tirzepatide (Zepbound) without insurance runs $1,000 to $1,300 per month in the US Retatrutide, as a next-generation triple agonist, will likely land at $1,200 to $1,800 per month at launch In Australia, the UK, and Canada, prices tend to be lower due to government drug pricing controls
These two medications are the most effective weight-loss injections available today and both can help you lose significant weight safely under physician supervision
Retatrutide vs Tirzepatide vs Semaglutide Three compounds dominate current GLP-1-class research conversation: semaglutide (single agonist), tirzepatide (dual agonist), and retatrutide (triple agonist) [3][4][9]
It describes the facial changes that can accompany rapid weight loss when using medications like Ozempic or another version of the same drug (generic name semaglutide) FDA-approved for weight-loss treatment
The advertised starting price at Hims & Hers covers medication only, before the mandatory $149/mo membership fee
US$ 20.33
US$ 27.28
US$ 27.19
US$ 25.15
US$ 28.06
